I’m excited to share my professional journey and the expertise I’ve developed over 41 years in clinical research and drug development. As the President and Founder of New England Clinical Consulting (NECC), I’ve had the privilege of leading clinical operations across the biotech and pharma sectors, working on therapeutic areas ranging from oncology to infectious diseases. Throughout my career, I’ve tackled complex challenges, built high-performing teams, and delivered successful clinical trials from early-phase development to global Phase 3 studies. I’m passionate about advancing clinical research, overseeing CROs, and developing innovative drug development strategies. If you’re interested in clinical operations or collaborating on new projects, I’d love to connect and explore how we can work together to drive impactful results.

I’m thrilled to share my updated executive biography, highlighting my journey and experiences in the biotech and pharma industries. With over 30 years of experience, I’ve had the privilege of leading clinical operations, managing complex programs, and working with exceptional teams to drive advancements in clinical research. My recent role as Senior Director of Clinical Operations at uniQure allowed me to deepen my expertise in clinical development, cross-functional team leadership, and strategic program management. I’m passionate about leveraging this experience to contribute to innovative projects and impactful organizations. Thank you for taking the time to read about my professional journey. I look forward to connecting and exploring new opportunities where I can bring my skills and dedication to make a difference.

Christopher Walters is an executive specializing in government relations, public affairs, and strategic planning, currently serving as Head of North America Public Affairs at Iveco Group. With extensive industry experience and expertise in energy and environmental policy, he advises on regulatory activities and strategic initiatives and plays a key role in industry trade groups.